New Age Alpha Advisors, LLC Gilead Sciences, Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.23 Trillion
- Q1 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 98,509 shares of GILD stock, worth $10.1 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
98,509
Previous 116,686
15.58%
Holding current value
$10.1 Million
Previous $10.8 Billion
2.41%
% of portfolio
0.49%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,284Shares Held
996MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$12.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.1 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.6 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.49 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $128B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...